Jeff Yass’s Maze Therapeutics MAZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-23,677
Closed -$657K – 14866
2026
Q2
$707K Sell
23,677
-1,624
-6% -$42.6K ﹤0.01% 9079
2026
Q1
$755K Buy
+25,301
New +$1.12M ﹤0.01% 8622
2025
Q4
– Sell
-16,165
Closed -$556K – 13985
2025
Q3
$419K Buy
16,165
+5,598
+53% +$94.5K ﹤0.01% 9367
2025
Q2
$130K Sell
10,567
-41
-0.4% -$427 ﹤0.01% 11611
2025
Q1
$117K Buy
+10,608
New +$128K ﹤0.01% 11434

Other funds holding MAZE

Jeff Yass's MAZE Position: Q3 2026 in Review

Jeff Yass sold out of Maze Therapeutics (MAZE) in Q3 2026, closing a stake of 23,677 shares — an estimated $657K sold.

Jeff Yass first reported a position in MAZE in Q1 2025 and held it in 5 quarters. The position peaked at $755K in Q1 2026. 158 funds tracked by Wall St. Rank hold MAZE as of Q3 2026.

  • Jeff Yass reported no remaining Maze Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Jeff Yass sold 23,677 Maze Therapeutics shares in Q3 2026, an estimated $657K.
  • Jeff Yass first reported a position in Maze Therapeutics in Q1 2025 and held it in 5 quarters.
  • Jeff Yass's Maze Therapeutics position peaked at $755K in Q1 2026.
  • 158 funds tracked by Wall St. Rank held Maze Therapeutics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.